AAAAAA

   
Results: 1-9 |
Results: 9
Synthesis and spectroscopic characterization of site-specific 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine oligodeoxyribonucleotide adducts
Authors: Brown, K Guenther, EA Dingley, KH Cosman, M Harvey, CA Shields, SJ Turteltaub, KW
Citation: K. Brown et al., Synthesis and spectroscopic characterization of site-specific 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine oligodeoxyribonucleotide adducts, NUCL ACID R, 29(9), 2001, pp. 1951-1959
A compact tritium AMS system
Authors: Roberts, ML Hamm, RW Dingley, KH Chiarappa-Zucca, ML Love, AH
Citation: Ml. Roberts et al., A compact tritium AMS system, NUCL INST B, 172, 2000, pp. 262-267
DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
Authors: Dingley, KH Curtis, KD Nowell, S Felton, JS Lang, NP Turteltaub, KW
Citation: Kh. Dingley et al., DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, CANC EPID B, 8(6), 1999, pp. 507-512
In vivo human metabolism of [2-C-14]2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP)
Authors: Lang, NP Nowell, S Malfatti, MA Kulp, KS Knize, MG Davis, C Massengill, J Williams, S MacLeod, S Dingley, KH Felton, JS Turteltaub, KW
Citation: Np. Lang et al., In vivo human metabolism of [2-C-14]2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP), CANCER LETT, 143(2), 1999, pp. 135-138
Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses
Authors: Turteltaub, KW Dingley, KH Curtis, KD Malfatti, MA Turesky, RJ Garner, RC Felton, JS Lang, NP
Citation: Kw. Turteltaub et al., Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses, CANCER LETT, 143(2), 1999, pp. 149-155
Comparative biotransformation studies of MeIQx and PhIP in animal models and humans
Authors: Garner, RC Lightfoot, TJ Cupid, BC Russell, D Coxhead, JM Kutschera, W Priller, A Rom, W Steier, P Alexander, DJ Leveson, SH Dingley, KH Mauthe, RJ Turteltaub, KW
Citation: Rc. Garner et al., Comparative biotransformation studies of MeIQx and PhIP in animal models and humans, CANCER LETT, 143(2), 1999, pp. 161-165
The identification of [2-C-14]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans
Authors: Malfatti, MA Kulp, KS Knize, MG Davis, C Massengill, JP Williams, S Nowell, S MacLeod, S Dingley, KH Turteltaub, KW Lang, NP Felton, JS
Citation: Ma. Malfatti et al., The identification of [2-C-14]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans, CARCINOGENE, 20(4), 1999, pp. 705-713
Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose
Authors: Mauthe, RJ Dingley, KH Leveson, SH Freeman, SPHT Turesky, RJ Garner, RC Turteltaub, KW
Citation: Rj. Mauthe et al., Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose, INT J CANC, 80(4), 1999, pp. 539-545
Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification
Authors: Turteltaub, KW Dingley, KH
Citation: Kw. Turteltaub et Kh. Dingley, Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification, TOX LETT, 103, 1998, pp. 435-439
Risultati: 1-9 |